Correction: New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney (PLoS ONE (2014) 9, 3 (e91646) DOI: 10.1371/journal.pone.0091646);New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Zaravinos, Apostolos ^a,e   Lambrou, George I ^b   Mourmouras, Nikos ^c   Katafygiotis, Patroklos ^c   Papagregoriou, Gregory ^a   Giannikou, Krinio ^d   Delakas, Dimitris ^c   Deltas, Constantinos ^a  

^a UNIVERSITY OF CYPRUS   (Cyprus)

^b UNIVERSITY OF ATHENS   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 142 5P; MICRORNA 148B 5P; MICRORNA 191 5P; MICRORNA 1912; MICRORNA 193B 3P; MICRORNA 24 2 5P; MICRORNA 24 3P; MICRORNA 26A 2 3P; MICRORNA 3117 3P; MICRORNA 3144 5P; MICRORNA 3164; MICRORNA 3615; MICRORNA 3648; MICRORNA 3656; MICRORNA 3687; MICRORNA 375; MICRORNA 378A 5P; MICRORNA 489; MICRORNA 514B 5P; MICRORNA 520B; MICRORNA 520C 3P; MICRORNA 587; MICRORNA 617; MICRORNA 638; MICRORNA 769 5P; MICRORNA 885 5P; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TFCP2L1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ALGORITHM; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; MIDDLE AGED; PHYLOGENY; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; TISSUE SECTION; TRANSITIONAL CELL CARCINOMA; TUMOR VOLUME; UPREGULATION; VERY ELDERLY; CHROMOSOME ABERRATION; COHORT ANALYSIS; CYTOLOGY; GENETICS; KIDNEY; KIDNEY TUMOR; METABOLISM; PATHOLOGY; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; UROTHELIUM;

EID: 84898417570     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100063     Document Type: Erratum

References (54)

1. Meloni-Ehrig AM (2002) Renal cancer: cytogenetic and molecular genetic aspects. Am J Med Genet 115: 164-172.
2. Ficarra V, Martignoni G, Galfano A, Novara G, Gobbo S, et al. (2006) Prognostic role of the histologic subtypes of renal cell carcinoma after slide revision. Eur Urol 50: 786-793.
3. Lopez-Beltran A, Kirkali Z, Cheng L, Egevad L, Regueiro JC, et al. (2008) Targeted therapies and biological modifiers in urologic tumors: pathobiology and clinical implications. Semin Diagn Pathol 25: 232-244.
4. Tazi el M, Essadi I, Tazi MF, Ahellal Y, M'Rabti H, et al. (2011) Advanced treatments in non-clear renal cell carcinoma. Urol J 8: 1-11.
5. Youssef YM, White NMA, Grigull J, Krizova A, Samy C, et al. (2011) Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur Urol 59: 721-730.
6. Fridman E, Dotan Z, Barshack I, David MB, Dov A, et al. (2010) Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn 12: 687-696.
7. Higgins JP, Kaygusuz G, Wang L, Montgomery K, Mason V, et al. (2007) Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol 31: 673-680. (Pubitemid 46684205)
8. Roupret M, Zigeuner R, Palou J, Boehle A, Kaasinen E, et al. (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 59: 584-594.
9. Kirkali Z, Tuzel E (2003) Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 47: 155-169. (Pubitemid 36945314)
10. Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, et al. (2007) MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26: 4148-4157. (Pubitemid 46920170)
11. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
12. Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, et al. (2010) Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem 43: 150-158.
13. White NM, Bao TT, Grigull J, Youssef YM, Girgis A, et al. (2011) miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol 186: 1077-1083.
14. Zaravinos A, Radojicic J, Lambrou GI, Volanis D, Delakas D, et al. (2012) Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer. J Urol 188: 615-623.
15. Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, et al. (2010) Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem 43: 150-158.
16. Fridman E, Dotan Z, Barshack I, Ben David M, Dov A, et al. (2010) Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn 12: 687-696.
17. Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, et al. (2009) MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 13: 3918-3928.
18. Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, et al. (2008) Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 216: 418-427.
19. Osanto S, Qin Y, Buermans HP, Berkers J, Lerut E, et al. (2012) Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing. PLoS One 7: e38298.
20. Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, et al. (2009) MicroRNA profiling of human kidney cancer subtypes. Int J Oncol 35: 109-114.
21. Radojicic J, Zaravinos A, Vrekoussis T, Kafousi M, Spandidos DA, et al. (2011) MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer. Cell Cycle 10: 507-517.
22. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, et al. (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392. (Pubitemid 47362758)
23. Huang Y, Dai Y, Yang J, Chen T, Yin Y, et al. (2009) Microarray analysis of microRNA expression in renal clear cell carcinoma. Eur J Surg Oncol 35: 1119-1123.
24. Juan D, Alexe G, Antes T, Liu H, Madabhushi A, et al. (2010) Identification of a microRNA panel for clear-cell kidney cancer. Urology 75: 835-841.
25. Yi Z, Fu Y, Zhao S, Zhang X, Ma C (2010) Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. J Cancer Res Clin Oncol 136: 855-862.
26. Sun Y, Koo S, White N, Peralta E, Esau C, et al. (2004) Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res 32: e188.
27. Zaravinos A, Bizakis J, Soufla G, Sourvinos G, Spandidos DA (2007) Mutations and differential expression of the ras family genes in human nasal polyposis. Int J Oncol 31: 1051-1059.
28. Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, et al. (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58: 398-406.
29. Roupret M, Zigeuner R, Palou J, Boehle A, Kaasinen E, et al. (2012) [European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract]. Actas Urol Esp 36: 2-14.
30. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838. (Pubitemid 40839735)
31. Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, et al. (2008) Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 216: 418-427.
32. Weng L, Wu X, Gao H, Mu B, Li X, et al. (2010) MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J Pathol 222: 41-51.
33. Spector Y, Fridman E, Rosenwald S, Zilber S, Huang Y, et al. (2013) Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas. Mol Oncol 7: 732-738.
34. Izquierdo L, Ingelmo-Torres M, Mallofre C, Lozano JJ, Verhasselt-Crinquette M, et al. (2013) Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma. BJU Int.
35. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004. (Pubitemid 38327724)
36. Girgis AH, Iakovlev VV, Beheshti B, Bayani J, Squire JA, et al. (2012) Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma. Cancer Res 72: 5273-5284.
37. Bratslavsky G, Sudarshan S, Neckers L, Linehan WM (2007) Pseudohypoxic pathways in renal cell carcinoma. Clin Cancer Res 13: 4667-4671. (Pubitemid 47294771)
38. Klatte T, Rao PN, de Martino M, LaRochelle J, Shuch B, et al. (2009) Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J Clin Oncol 27: 746-753.
39. Kovacs G, Fuzesi L, Emanual A, Kung HF (1991) Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer 3: 249-255.
40. Speicher MR, Schoell B, du Manoir S, Schrock E, Ried T, et al. (1994) Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol 145: 356-364. (Pubitemid 24245836)
41. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, et al. (1997) Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80: 987-989.
42. van den Berg E, Dijkhuizen T, Oosterhuis JW, Geurts van Kessel A, de Jong B, et al. (1997) Cytogenetic classification of renal cell cancer. Cancer Genet Cytogenet 95: 103-107. (Pubitemid 27188453)
43. Velickovic M, Delahunt B, Storkel S, Grebem SK (2001) VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance. Cancer Res 61: 4815-4819. (Pubitemid 32691896)
44. Yoshimoto T, Matsuura K, Karnan S, Tagawa H, Nakada C, et al. (2007) High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. J Pathol 213: 392-401. (Pubitemid 350206511)
45. Thapa RJ C, Cheung M, Nogusa S, Pei J, Peri S, et al. (2013) NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinoma. Mol Cancer Ther 12: 1568-1578.
46. Sato A, Nagase H, Obinata D, Fujiwara K, Fukuda N, et al. (2013) Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma. Int J Oncol 43: 1441-1446.
47. Zaravinos A, Pieri M, Mourmouras N, Anastasiadou N, Zouvani I, et al. (2014) Altered metabolic pathways in clear cell renal cell carcinoma: A meta-analysis and validation study focused on the deregulated genes and their associated networks. Oncoscience, Advance Publications.
48. Aggarwal BB, Gehlot P (2009) Inflammation and cancer: how friendly is the relationship for cancer patients? Curr Opin Pharmacol 9: 351-369.
49. Wu Y, Fu X, Zhu X, He X, Zou C, et al. (2011) Prognostic role of systemic inflammatory response in renal cell carcinoma: a sytemic review and meta-analysis. J Cancer Res Clin Oncol 137: 887-896.
50. Feng Z, Zhang C, Wu R, Hu W (2011) Tumor suppressor p53 meets microRNAs. J Mol Cell Biol 3: 44-50.
51. Yamada Y, Hidaka H, Seki N, Yoshino H, Yamasaki T, et al. (2013) Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma. Cancer Sci 104: 304-312.
52. Wach S, Nolte E, Theil A, Stöhr C, T Rau T, et al. (2013) MicroRNA profiles classify papillary renal cell carcinoma subtypes. Br J Cancer 109: 714-722.
53. Teicher BA, Linehan WM, Helman LJ (2012) Targeting cancer metabolism. Clin Cancer Res 18: 5537-5545.
54. Tun HW, Marlow LA, von Roemeling CA, Cooper SJ, Kreinest P, et al. (2010) Pathway signature and cellular differentiation in clear cell renal cell carcinoma. PLoS One 5: e10696.